6YH Stock Overview
Operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Sopharma Trading AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв42.08 |
| 52 Week High | лв0 |
| 52 Week Low | лв0 |
| Beta | 0.27 |
| 11 Month Change | 0% |
| 3 Month Change | 1.70% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6YH | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | 1.0% |
| 1Y | n/a | 5.5% | 11.2% |
Return vs Industry: Insufficient data to determine how 6YH performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how 6YH performed against the German Market.
Price Volatility
| 6YH volatility | |
|---|---|
| 6YH Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6YH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 6YH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,582 | Ventsislav Marinov | www.sopharmatrading.bg |
Sopharma Trading AD operates as a trading company in the pharmaceutical sector in Bulgaria and Serbia. The company offers its customers approximately 10,000 pharmaceutical products, including a portfolio of various brands, medicines, medical devices, sanitary materials, vitamins, food supplements, cosmetics, medical appliances, and equipment. It also provides logistic solutions for the import, storage, and distribution of pharmaceutical products, as well as services on the positioning of the products on the hospital and pharmacy markets.
Sopharma Trading AD Fundamentals Summary
| 6YH fundamental statistics | |
|---|---|
| Market cap | €87.57m |
| Earnings (TTM) | €6.83m |
| Revenue (TTM) | €704.10m |
12.8x
P/E Ratio0.1x
P/S RatioIs 6YH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6YH income statement (TTM) | |
|---|---|
| Revenue | лв1.38b |
| Cost of Revenue | лв1.23b |
| Gross Profit | лв150.29m |
| Other Expenses | лв136.91m |
| Earnings | лв13.38m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 10.91% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | 210.5% |
How did 6YH perform over the long term?
See historical performance and comparison